xterna

London, United Kingdom

Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.

$526K raised

Feb 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has xterna raised?

xterna has raised $526K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.

Who are xterna's investors?

xterna's investors include BioInnovation Institute Venture Lab, Vehiculum Capital.

Where is xterna headquartered?

xterna is headquartered in London, United Kingdom.

What does xterna do?

Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.

What stage is xterna at?

xterna is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2025.

MLA

"xterna — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/xterna. Accessed July 3, 2026.

APA

VCBacked. (2025). xterna — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/xterna

Wikipedia (cite web)

{{cite web |title=xterna — Funding & Investors |url=https://www.vcbacked.co/company/xterna |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2025.